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The incidence rate of schizencephaly is 1.5 in 100,000 live births and the rate of 
holoprosencephaly is 1 in 16,000 live births. Both malformations are rare, but our institution has 
seen a dramatic increase in both malformations in recent years with no known cause. 
Schizencephaly is the most severe cortical malformation and holoprosencephaly is the most 
common defect in the prosencephalon during development. However, it is still not very common 
to see a fetus with this defect live to delivery. Our institution, a regional hospital in central 
Appalachia, has seen four cases of schizencephaly and three cases of holoprosencephaly within 
two years. No two neonates seem to share a common factor. All had different co-morbidities and 
presentations, all mothers were of different ages and showed few risk factors if any for these 
deformities. This paper is a report of the cases found of these rare birth defects seen at our 








Our institution, a regional hospital in central Appalachia, has seen an unusual increase in brain 
abnormalities over the past ten years with no obvious cause, with a cluster of severe congenital 
brain malformations in the last thirty months. These malformations include schizencephaly and 
holoprosencephaly. Schizencephaly is the most severe form of a cortical malformation.1 
Schizencephaly is estimated to affect 1.5 out of 100,000 live births. The clefting of the cerebral 
mantle most commonly occurs in the frontal lobes but can occur in the parietal lobe as well.2 
Schizencephaly symptoms include developmental delays, speech and language difficulties, 
brain-spinal cord communication problems, microcephaly, hydrocephalus, seizures, complete or 
partial paralysis, and abnormal muscle tone. The severity of the persons’ symptoms depends on 
cleft severity and the presence of other brain abnormalities.3 There is no known cause of 
schizencephaly, but it has been linked to genes EMX2, SIX3, SHH, and COL4A1. There are also 
non-genetic links such as maternal age under twenty-four years old, infections during gestation 
specifically cytomegalovirus infection (CMV), folate deficiency, and exposure to medication 
during development that can interrupt blood flow before birth.4,5 There is no cure for this 
malformation. There is still little known about schizencephaly and more research needs to be 
done in this area.  
 
Holoprosencephaly (HPE) is the most common malformation of the prosencephalon, occurring 
in 1 in 250 embryos and 1 in 16,000 live births.6 This defect will occur within the first four 
weeks of embryogenesis; it is said to be as specific as between the 18th and 28th day after 
conception. HPE affects 3-4% of all live births.7,8 HPE is a nonseparation of the deep grey 
nuclei, and this is used to diagnose a spectrum of disorders with the same etiology. Of this 
spectrum of disorders, the diagnoses are graded on the degree of non-separation of the nuclei. 
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The severity of the craniofacial malformations is dependent on the degree of nonseparation of the 
grey nuclei. With HPE cases it has been said that “the face follows the brain” meaning the 
severity of the malformation will correlate to the separation or lack thereof within the brain.6,9,10 
The risk factors for a fetus developing HPE can include a maternal obstetrical history of a 
previous spontaneous abortion, first trimester bleeding during the pregnancy in question or 
previous pregnancies, and/or chromosomal abnormalities. Several of the recognized maternal 
risk factors are diabetes mellitus gestational or chronic, alcoholism, smoking, prenatal exposure 
to retinoic acid, cholesterol biosynthetic inhibitors, infections, and hypothyroidism.10 Other 
possible risk factors include the use of contraceptives, before or early during the pregnancy, the 
use of salicylates, hypocholesterolemia, low-calorie diets, and cholesterol synthesis via the Sonic 
hedgehog (SHH) pathway.11  
 
The population our institution serves has had numerous high-risk factors for these brain 
malformations for years with the highest rate nationally for diabetes12, smoking during 
pregnancy12,13, and heart disease.13 Considering all of the risk factors and the prevalence of these 
decreasing within this population over the past few years, it is unclear what could have caused a 
seemingly random spike in the rates of these very specific birth defects or why these are the first 
our institution has seen. When based on the rates of teratogens from previous years present in 
this population, we should have been seeing them all along. This study aims to discuss this 





The finding of a single case of HPE is rare; the rate of HPE in live births is 1 in 16,000 
newborns. Within two years our institution diagnosed four cases of schizencephaly. Also, during 
these two years, in less than seven months, our institution saw and diagnosed three cases of HPE, 
two males and one set of female twins; only one of the twins was formally diagnosed with HPE. 
There are no shared risk factors or genetic abnormalities among the presented cases. These 
neonates have no obvious cause of this malformation, and they all have very little if anything in 
common. The information about each of these neonates at birth and during pregnancy can be 




A retrospective analysis was completed to further examine the incidence of these two rare central 
nervous system malformations seen from 2017 until 2019. The schizencephaly cases are 
diagnosed by the degree of clefting seen in the cerebral mantle of the various lobes of the brain. 
Holoprosencephaly was confirmed by a lack of separation of the two hemispheres of the brain. 
All seven neonates’ diagnoses were confirmed radiographically. 
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Neonate 1 2 3 4 5 6 7 
Diagnosis Schizencephaly Holoprosencephaly Holoprosencephaly Schizencephaly Holoprosencephaly Schizencephaly Schizencephaly 
Gender male male male male female female female 
Delivery repeat cesarean cesarean vaginal  cesarean cesarean vaginal cesarean 
Gestation age in 
weeks 
30 27.5 36 34 31 36 32 



















26 24.5 31 28 26 30 23 
APGAR scores 
1,5 minute 




fetal heart rate 





fetal heart rate 
Maternal Age in 
years 
28 17 18 22 37 18 27 
Gravida Para 2,1 1,0 1,0 2,1 3,2 2,1 2,1 
Maternal Blood 
type 
A+ O+ AB+ A+ O+ O+ B+ 















• Opiates  
• Oxycodone 
• Barbiturates  





• ranitidine  







































tobacco use, alcohol 
use, advanced 
maternal age, stage 















•  tobacco use 
• Tobacco use • None identified 
• Maternal age 
under 24 
• Alcohol use 








































Table 1 This table compares the details of each case including the gestational age, weight, head circumference, APGAR scores, exposure to 
maternal medicines and substances and other details of the gestations and maternal history. The results of any genetic testing are also listed in 
the table above. All cases were determined by the treating physician to be small for gestational age (SGA).  
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Results 
  
In the ten years from January first to the end of December 2019, seven neonates were born 
weighing 800 grams or greater and were diagnosed by the treating physicians as small for 
gestational age.14 Of these seven neonates, three were diagnosed with holoprosencephaly and the 
remaining four were diagnosed with schizencephaly. The details of these neonates can be seen in 




The population in West Virginia has significant co-morbidities and lifestyle choices that all align 
with the literature for potential risk factors of brain malformation. Despite the high number of 
risk factors, no congenital brain malformations had been identified at our institution since the 
installation of our electronic medical record in 2008, with no memory of additional cases from 
long-time staff. We have described the geographic cluster of rare and debilitating 
encephalopathies. With no previous cases recorded or in memory of the staff, and as rare as these 
malformations are embryologically, seven cases in just over two years is statistically improbable.   
 
The children with schizencephaly (chronologically - 1, 4, 6, and 7) do not appear to have any 
common risk factors. The first had no risk factors that have been described in the literature. 
However, the mother did use multiple illicit substances (including opioids, amphetamines, and 
marijuana) of unknown quantities throughout her pregnancy. We can only speculate if this was a 
contributing factor to the malformation in this neonate. The fourth neonate’s mother was 22 
years old which is considered a risk factor for schizencephaly and upon genetic testing, it was 
found that the neonate had a gene duplication that was not thought to contribute to the brain 
malformation; the mother had no other risk factors described in the literature. The sixth 
neonate’s mother was 18 years old and she had a previous spontaneous abortion; no genetic 
testing was performed for this child and so a contributing genetic variant cannot be identified as 
the cause but no other risk factors were found in the mother’s history. The last child seen with 
schizencephaly had a confirmed CMV infection during gestation as the only confirmed risk 
factor.  
 
The children with holoprosencephaly (chronologically - 2, 3, and 5), like the schizencephaly, 
have little identified commonalities. The second child had no abnormalities on genetic testing. 
The mother did admit to smoking cigarettes during her pregnancy with no other risk factors.  The 
third child no known genetic abnormalities, no previous spontaneous abortion (SAB), no first 
trimester bleeding, no reported diabetes mellitus, no reported alcohol consumption, or tobacco 
usage during the pregnancy. This neonate was the only child that has no identified risk factors 
for this malformation. Whereas the fifth neonate had the most risk factors of all seven, this 
mother had many issues with her previous pregnancies, and the pregnancy discussed in this 
paper was complicated with multiple fetuses and polyhydramnios. The mother also admitted to 
smoking cigarettes and using alcohol during her pregnancy. Lemonie reported in a paper from 
1968 that on the more severe end of the fetal alcohol spectrum there were malformations of the 
brain some of which include semi-lobar holoprosencephaly and agenesis or absence of the 
corpus callosum.15  
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The first, third, and fourth neonates received genetic testing by microarray-based Comparative 
Genomic Hybridization (CGH); the first and third neonates were negative and the fourth was 
considered to have a minor duplication of no consequence to this malformation. In all seven 
cases, the umbilical cords were normal and unremarkable, except for the sixth whose cord was 
dried, and abnormalities could not be detected.  
 
There was one common factor across the neonates in this series: all seven children discussed 
here were small for gestational age, which is unusual in this population. Fetal insulin is the 
hormonal regulator for fetal growth during gestation, the amount of insulin is dependent on the 
amount of glucose the fetus attains from the mother’s blood.16,17 The maternal BMI can be seen 
in Table 1. BMI has been correlated to insulin secretion and sensitivity.18,19 Fetal insulin 
secretion is the primary regulator for growth during development, if the mother had an increased 
glycemic index it would be more likely for their child to be appropriate or large for their 
gestational age. However, in the seven children, we have seen with these malformations only two 
of the mothers (the fourth and fifth) were overweight and both neonates were still small for their 
gestational age. The mothers of the third, sixth, and seventh all had BMIs in the normal range 
and the children were also small for gestational age. The first and second mothers’ information 
on their BMIs could not be found.  
 
It is likely we will not find the definitive cause of these malformations. More research needs to 
be done into the causes of the malformations and the rural Appalachian population. It is not clear 
what may have caused this crop of encephalopathies in such a short time or if this is not an 
arbitrary occurrence and this is the new normal for our population. We need more research into 
the causes and the treatments of these malformations to best serve our community.  
 
Within the last ten years, two other clusters of birth defects have been seen at our institution. The 
two clusters that have been seen were five cases of myelomeningocele within two years and six 
cases of imperforated anus over ten years; however, four of these cases were within two years. 
Due to the proximity geographically of these cases to one another, environmental teratogenic 
exposure has been hypothesized and should be explored for a more complete investigation as to 
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Our institution has witnessed a recent and unprecedented increase in infants diagnosed with 
schizencephaly and holoprosencephaly with no known cause. A timeline with these cases can be 
seen in Graph 1. The population we serve exhibits a great many risk factors and co-morbidities 
and has for years. However, we are only now seeing the presentation of this malformation and 
other birth abnormalities with no obvious cause. Without more information about the 
pregnancies and exposures, we can only speculate as to the causes. To find such a cause and/or 
more risk factors that can lead to the development of this encephalopathy, more research and 
investigation needs to be done.  
Graph 1 This graph is a timeline of brain malformations seen at our institution from 2009 to 2019.  
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